![]() |
|
#11
|
|||
|
Not part of the company that was researching this so I don't care about sharing this. Plus not even in the country... so yeah
++ enough has been covered to avoid any legal concerns. VIREM flagged as a rabies compound, REGUL mock-approved it kinda of a bad cautionary case study case Its an interesting example how we interpret AI-driven review logic. We ran VIREM* on archived neuroinfection trial data. It’s a visual analytics model trained on histopathology and molecular imaging—used mostly for retrospective pattern detection. It flagged a compound: CLBr₂-*Lumin. This one had been shelved after Phase II due to inconsistent efficacy and lack of toxicology follow-up. As part of a documentation stress test, we submitted the full package to REGUL*, our internal FDA simulation tool. REGUL* models procedural flow and decision logic based on historical approval patterns, including integration of public health sentiment data. Unexpectedly, REGUL* issued a conditional approval. The reasoning stemmed from a sentiment overlay included in the report. VIREM* integrates with SOCNE*, which aggregates public discourse using NLP and trend mapping. It flagged a rise in associative language—terms like “purge,” “cleanse,” “neural reset”—from speculative discussions that mentioned the compound in passing. REGUL* interpreted that as a signal of narrative alignment, which it weights as a soft proxy for public acceptance. The final note included a warning: “WARNING: Under no circumstances should CLBr₂-*Lumin be co-administered with sodium hypochlorite or oxidizing agents. Simulated models indicate risk of neurotoxicity and systemic oxidative cascade. Emergency protocols must be in place prior to administration.” To be clear, this was a mock approval in a sandboxed environment. No real-world authorization was granted, and the compound remains untested in current clinical settings. But the case highlights a broader issue: when AI systems incorporate public sentiment as part of their decision logic, they may overvalue linguistic trends that lack scientific grounding. This aligns with recent findings from Stanford’s Center for Biomedical Informatics, which cautioned against using social media-derived sentiment as a standalone metric in clinical AI models. FDA guidance also emphasizes that real-world evidence must be contextualized and validated—not inferred from public discourse alone. We’ve since reviewed REGUL*’s weighting system and flagged the sentiment vector for stricter thresholds. It’s a useful reminder that AI can simulate policy, but it doesn’t replace expert judgment. Especially in regulatory contexts, transparency and traceability matter. If anyone is wondering... the president loves sodium hypochlorite placed in the body [You must be logged in to view images. Log in or Register.] LoL | ||
|
|